Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

Clinical trial NCT02808442 · COMPLETED

Trial details

NCT number: NCT02808442
Sponsor: Institut de Recherches Internationales Servier
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory B-cell Acute Lymphoblastic Leukemia Relapsed B-cell Acute Lymphoblastic Leukemia

Start date: 2016-06-03
Primary completion: 2020-09-17
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.